{"SPADE_UN_28287": {"Sequence Information": {"Peptide Name": "*VVRG*", "Sequence": "WVLVLRLGY", "Sequence Length": 9, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Antifungal", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [], "Literature": [{"Title": "Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: the importance of interfacial activity", "Pubmed ID": "19445503", "Reference": "J Am Chem Soc. 2009;131:7609-7617", "Author": "Rathinakumar R, Walkenhorst WF, Wimley WC", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/19445503"}, {"Title": "A lack of synergy between membrane-permeabilizing cationic antimicrobial peptides and conventional antibiotics.", "Pubmed ID": "25268681", "Reference": "Biochim Biophys Acta. 2015;1848:8-15", "Author": "He J, Starr CG, Wimley WC", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/25268681"}], "Mass": 1118.37, "PI": 8.75, "Net Charge": 1, "Hydrophobicity": 1.41, "Frequent Amino Acids": "LVG", "Absent Amino Acids": "ACDEFHIKMNOPQSTU", "Basic Residues": 1, "Acidic Residues": 0, "Hydrophobic Residues": 5, "Polar Residues": 4, "Positive Residues": 1, "Negative Residues": 0, "SPADE ID": "SPADE_UN_28287", "Similar Sequences": [{"SPADE_ID": "SPADE_N_01926", "Similarity": 1.0, "Sequence": "FPPWVL"}, {"SPADE_ID": "SPADE_N_11438", "Similarity": 1.0, "Sequence": "FWRWWVL"}, {"SPADE_ID": "SPADE_UN_02714", "Similarity": 1.0, "Sequence": "KWRAAQWVL"}], "Hemolytic Activity": "Human erythrocytes:21% Hemolysis=15 µM,Sheep erythrocytes:16% Hemolysis=15 µM", "Target Organism": "Escherichia coli ATCC 25922(MSC=2.9±1.6µM),Staphylococcus aureus ATCC 25923(MSC=4.8±0.8µM),Pseudomonas aeruginosa ATCC 27853(MSC=7.2±1.4µM),Cryptococcus neoformans ATCC 66031(MSC=>10µM)"}}}